Rahbari, N. N., Reißfelder, C., Schulze-Bergkamen, H., Jäger, D., Büchler, M. W., Weitz, J., & Koch, M. (2014). Adjuvant therapy after resection of colorectal liver metastases: The predictive value of the MSKCC clinical risk score in the era of modern chemotherapy. BMC cancer, 14, . https://doi.org/10.1186/1471-2407-14-174
Chicago Style (17th ed.) CitationRahbari, Nuh Nabi, Christoph Reißfelder, Henning Schulze-Bergkamen, Dirk Jäger, Markus W. Büchler, Jürgen Weitz, and Moritz Koch. "Adjuvant Therapy After Resection of Colorectal Liver Metastases: The Predictive Value of the MSKCC Clinical Risk Score in the Era of Modern Chemotherapy." BMC Cancer 14 (2014). https://doi.org/10.1186/1471-2407-14-174.
MLA (9th ed.) CitationRahbari, Nuh Nabi, et al. "Adjuvant Therapy After Resection of Colorectal Liver Metastases: The Predictive Value of the MSKCC Clinical Risk Score in the Era of Modern Chemotherapy." BMC Cancer, vol. 14, 2014, https://doi.org/10.1186/1471-2407-14-174.